We describe here a comparative transcriptome analysis of CML patients and HC subjects, highlighting the lower expression of HOTAIR and PTGS2 in CML patients, which may be related to disease status and imatinib treatment. The gene discussed is HOTAIR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.